Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Neeta Pandit-Taskar
Affiliation
Memorial Sloan Kettering Cancer Center
ORCID
Career Start Year
1996
Papers
158
H Index
41
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36114654
Imaging recommendations in pediatric lymphoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Pediatr Blood Cancer
2023
36958856
Summary: Appropriate Use Criteria for Lymphoscintigraphy in Sentinel Node Mapping and Lymphedema/Lipedema.
J Nucl Med
2023
37250482
Prolonged generalized immune response on <sup>18</sup>F-FDG PET/CT following COVID-19 vaccination.
Radiol Case Rep
2023
37011647
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.
Lancet Diabetes Endocrinol
2023
37406106
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.
Clin Cancer Res
2023
36522184
Artificial Intelligence in Nuclear Medicine: Opportunities, Challenges, and Responsibilities Toward a Trustworthy Ecosystem.
J Nucl Med
2023
36853490
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma.
J Neurooncol
2023
36418168
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using <sup>89</sup>Zr-Trastuzumab PET: A Pilot Study.
J Nucl Med
2023
36759197
Radioimmunoscintigraphy and Pretreatment Dosimetry of <sup>131</sup>I-Omburtamab for Planning Treatment of Leptomeningeal Disease.
J Nucl Med
2023
36070194
Imaging of pediatric extremity soft tissue tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Pediatr Blood Cancer
2023
36173459
Molecular imaging of sarcomas with FDG PET.
Skeletal Radiol
2023
36165682
Imaging of pediatric thyroid tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Pediatr Blood Cancer
2023
36349892
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.
Pediatr Blood Cancer
2023
34413145
CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody.
J Nucl Med
2022
35839540
Clinical and imaging experience with COVID-19 in nonvaccinated children with cancer.
Clin Imaging
2022
35403968
Quantifying intraventricular drug delivery utilizing programmable ventriculoperitoneal shunts as the intraventricular access device.
J Neurooncol
2022
35403861
Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre.
Eur J Nucl Med Mol Imaging
2022
35376991
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0.
Eur J Nucl Med Mol Imaging
2022
35523007
Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management.
Transl Oncol
2022
35450957
Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center.
J Nucl Med
2022
36539908
Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors.
Cancer Imaging
2022
36371226
Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.
J Hematol Oncol
2022
36040037
Clinicopathologic and Prognostic Features of Pediatric Follicular Cell-derived Thyroid Carcinomas: A Retrospective Study of 222 Patients.
Am J Surg Pathol
2022
35223381
Molecular Immune Targeted Imaging of Tumor Microenvironment.
Nanotheranostics
2022
34857661
Biodistribution and Radiation Dosimetry of Intraperitoneally Administered <sup>124</sup>I-Omburtamab in Patients with Desmoplastic Small Round Cell Tumors.
J Nucl Med
2022
35247915
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.
Clin Cancer Res
2022
35273095
Reply: Single-Time-Point Tumor Dosimetry Assuming Normal Distribution of Tumor Kinetics.
J Nucl Med
2022
34993893
F-18 meta-fluorobenzylguanidine PET imaging of myocardial sympathetic innervation.
J Nucl Cardiol
2022
34667111
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis.
Mol Cancer Ther
2022
34550529
ImmunoPET: harnessing antibodies for imaging immune cells.
Mol Imaging Biol
2022
34750237
Radiation Safety Considerations and Clinical Advantages of α-Emitting Therapy Radionuclides.
J Nucl Med Technol
2022
34620729
<sup>18</sup>F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma.
J Nucl Med
2022
33047248
IntraOmmaya compartmental radioimmunotherapy using <sup>131</sup>I-omburtamab-pharmacokinetic modeling to optimize therapeutic index.
Eur J Nucl Med Mol Imaging
2021
33685867
High-Specific-Activity-<sup>131</sup>I-MIBG versus <sup>177</sup>Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.
Clin Cancer Res
2021
33495310
Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [<sup>64</sup>Cu]Cu-NOTA-anti-CD8 PET.
Clin Cancer Res
2021
33495926
A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals.
Eur J Nucl Med Mol Imaging
2021
34857623
Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice.
J Nucl Med
2021
34857617
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns.
J Nucl Med
2021
34418873
FDG PET/CT imaging features and clinical utility in COVID-19.
Clin Imaging
2021
33990084
Evaluation of a patient-specific algorithm for predicting distribution for convection-enhanced drug delivery into the brainstem of patients with diffuse intrinsic pontine glioma.
J Neurosurg Pediatr
2021
34088618
A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer.
Clin Genitourin Cancer
2021
33249143
A Framework for Patient-Centered Pathways of Care for Radiopharmaceutical Therapy: An ASTRO Consensus Document.
Int J Radiat Oncol Biol Phys
2021
33334912
SNMMI Procedure Standard/EANM Practice Guideline on Pediatric <sup>18</sup>F-FDG PET/CT for Oncology 1.0.
J Nucl Med
2021
33246639
Novel Agents and Future Perspectives on Theranostics.
Semin Radiat Oncol
2021
31562942
Restaging [<sup>18</sup>F] fludeoxyglucose positron emission tomography/computed tomography scan in recurrent cutaneous squamous cell carcinoma: Diagnostic performance and prognostic significance.
J Am Acad Dermatol
2020
31996149
Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies.
BMC Med Imaging
2020
31924717
Positron Lymphography via Intracervical <sup>18</sup>F-FDG Injection for Presurgical Lymphatic Mapping in Cervical and Endometrial Malignancies.
J Nucl Med
2020
32005772
Assessing Cerebrospinal Fluid Flow Dynamics in Pediatric Patients with Central Nervous System Tumors Treated with Intraventricular Radioimmunotherapy.
J Nucl Med
2020
33059826
Immune-Directed Molecular Imaging Biomarkers.
Semin Nucl Med
2020
33119478
B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study.
J Clin Oncol
2020
1 - 50 of 158
Column Actions
Search
Recommended Authors
Jeremie Calais
university of california los angeles
Career Start Year
2014
Number of shared co-authors
9
Vincenzo Paolillo
UT MD Anderson Cancer Center
Career Start Year
2009
Number of shared co-authors
0
Pedram Heidari
Massachusetts General Hospital
Career Start Year
2008
Number of shared co-authors
4
Spencer C Behr
University of California san francisco
Career Start Year
2007
Number of shared co-authors
3
Guido Davidzon
Stanford University
Career Start Year
2005
Number of shared co-authors
0
Nina Tunariu
The Institute of Cancer Research
Career Start Year
2005
Number of shared co-authors
10
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year
2005
Number of shared co-authors
0
Albert J Chang
University of California Los Angeles
Career Start Year
2003
Number of shared co-authors
4
Zhaohui Zhu
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year
2000
Number of shared co-authors
2
Austin N Kirschner
Vanderbilt University Medical Center
Career Start Year
2000
Number of shared co-authors
0
Chuong Bui
Nepean Hospital
Career Start Year
1999
Number of shared co-authors
0
Lance T Hall
University of Wisconsin Hospitals and Clinics
Career Start Year
1998
Number of shared co-authors
0
Nobuyuki Kosaka
University of Fukui.
Career Start Year
1997
Number of shared co-authors
0
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year
1997
Number of shared co-authors
2
Carolien P Schr??der
University of Groningen, University Medical Center Groningen
Career Start Year
1995
Number of shared co-authors
2
Baixuan Xu
First Medical Center, Chinese PLA General Hospital
Career Start Year
1994
Number of shared co-authors
1
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year
1994
Number of shared co-authors
1
Kevin Camphausen
National Cancer Institute
Career Start Year
1994
Number of shared co-authors
1
David M Peereboom
Brain Tumor & Neuro-Oncology Cleveland Clinic Main Campus
Career Start Year
1993
Number of shared co-authors
0
Philippe Lambin
Maastricht University
Career Start Year
1992
Number of shared co-authors
8
Juri G Gelovani
Karmanos Cancer Institute (KCI), Wayne State University
Career Start Year
1990
Number of shared co-authors
2
Hisataka Kobayashi
Center for Cancer Research
Career Start Year
1990
Number of shared co-authors
0
Magnus Dahlbom
David Geffen School of Medicine, university of california los angeles
Career Start Year
1988
Number of shared co-authors
5
Johannes Czernin
university of california los angeles
Career Start Year
1987
Number of shared co-authors
10
Javier E Villanueva-Meyer
University of California san francisco
Career Start Year
1986
Number of shared co-authors
1
Martin W Brechbiel
National Institutes of Health
Career Start Year
1985
Number of shared co-authors
4
James R Bading
City of Hope National Medical Center
Career Start Year
1982
Number of shared co-authors
1
Jiahe Tian
First Medical Center of Chinese PLA General Hospital
Career Start Year
1982
Number of shared co-authors
1
Peter L Choyke
National Cancer Institute, National Institutes of Health
Career Start Year
1982
Number of shared co-authors
12
Peter S Conti
Keck School of Medicine of USC
Career Start Year
1971
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
John L Humm
Memorial Sloan Kettering Cancer Center
Co-authored papers
22
Michael J Morris
Memorial Sloan Kettering Cancer Center
Co-authored papers
21
Chaitanya Divgi
Columbia University Medical Center Kreitchman PET Center
Co-authored papers
19
Howard I Scher
Memorial Sloan Kettering Cancer Center
Co-authored papers
16
Mithat Gonen
Co-authored papers
12
Mark M Souweidane
New York Presbyterian and Memorial Sloan Kettering Cancer Center
Co-authored papers
9
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Co-authored papers
8
Lloyd J Old
Ludwig Institute for Cancer Research
Co-authored papers
8
Richard L Wahl
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Co-authored papers
6
Milan Grkovski
Memorial Sloan Kettering Cancer Center
Co-authored papers
6
Richard K G Do
Memorial Sloan Kettering Cancer Center
Co-authored papers
4
Babak Saboury
Clinical Center
Co-authored papers
4
Dana E Rathkopf
Memorial Sloan Kettering Cancer Center
Co-authored papers
4
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers
4
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers
4
Thomas A Hope
University of California san francisco
Co-authored papers
4
Jeremy C Durack
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Stephen B Solomon
Memorial Sloan-Kettering Cancer Center
Co-authored papers
3
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Jeffrey P Greenfield
Weill Cornell Medical Center, NewYork Presbyterian Hospital
Co-authored papers
3
Karel Pacak
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Co-authored papers
3
Rebecca Nagy
Guardant Health Inc.
Co-authored papers
2
Bhuvanesh Singh
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Andre Konski
Chester County Hospital
Co-authored papers
2
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Massimo Loda
Weill Medical College of Cornell University
Co-authored papers
2
Angelo Nacca
Istituto di Ricerche Farmacologiche Mario Negri
Co-authored papers
2
Randy Yeh
Department of Radiology Memorial Sloan Kettering Cancer Center
Co-authored papers
2
David M Nanus
Sandra and Edward Meyer Cancer Center
Co-authored papers
2
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
1
1 - 30